Life Biosciences has received FDA clearance to begin a first-in-human Phase 1 clinical trial of ER-100, a gene therapy ...

Blindness itself might become, at least in certain cases, partially reversible. This potential future stems from one of the ...

Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.

A team linked to Harvard Medical School has dosed the first patient in a clinical trial designed to reverse cellular aging in ...

On 19 January, co-founders Rick Klausner and Hans Bishop publicly launched an aging research initiative called Altos Labs, with $3 billion in initial financing from backers including tech investor ...

EPFL researchers have uncovered how transcription factor dosage reshapes cell identity, showing that even small differences in dose can steer cells toward completely different fates. Their findings ...

Researchers are decoding how signals move between body and brain, with implications for how we understand and treat ...

In order to reprogram readily available cells into specific immune cells that fight various diseases, one must know the "recipe" for the transformation. Researchers at Lund University have now created ...